- Medtronic (NYSE: MDT ) reported second quarter EPS of $1.26, $0.01 better than the analyst estimate of $1.25. Revenue for the quarter came in at $8.4B versus the consensus estimate of $8.28B.

Guidance

Medtronic sees FY 2025 EPS of $5.44-$5.50 versus the analyst consensus of $5.45.

Medtronic's stock price closed at $87.59. It is down -0.27% in the last 3 months and up 16.54% in the last 12 months.

Medtronic saw 2 positive EPS revisions and 18 negative EPS revisions in the last 90 days. See Medtronic's stock price’s past reactions to earnings here .

According to InvestingPro , Medtronic's Financial Health score is " good performance ".

Check out Medtronic's recent earnings performance , and Medtronic's financials here .

Stay up-to-date on all of the upcoming earnings reports by visiting 's earnings calendar